Rubrik, Inc. (RBRK) Q2 2025 Earnings Call Transcript Summary
Rubrik, Inc. (RBRK) Q2 2025 Earnings Call Transcript Summary
The following is a summary of the Rubrik, Inc. (RBRK) Q2 2025 Earnings Call Transcript:
以下是Rubrik, Inc.(RBRK)2025年第二季度财报电话会议记录摘要:
Financial Performance:
财务业绩:
Rubrik reported significant growth in Q2 with a Subscription ARR of $919 million, marking a year-over-year increase of 40%.
Subscription revenue for the quarter was $191 million, a 50% increase year-over-year.
Reported a robust subscription ARR contribution margin improvement of over 1300 basis points year-over-year.
Rubrik报告称,第二季度实现了显著增长,订阅年利率为9.19亿美元,同比增长了40%。
该季度的订阅收入为1.91亿美元,同比增长50%。
报告称,订阅ARR的供款利润率同比增长了1300多个基点。
Business Progress:
业务进展:
Rubrik continues to lead in the cyber resilience market, focusing on integrating DSPM with cyber recovery.
Enhanced partnerships, notably with Mandiant and recognition as Microsoft's Healthcare and Life Sciences Partner of the Year.
Introduced AI agent, Ruby, as part of the Enterprise Edition for advancing IT and security operations productivity.
Rubrik继续在网络弹性市场处于领先地位,专注于将dsPM与网络恢复相结合。
加强了合作伙伴关系,尤其是与 Mandiant 的合作伙伴关系,并被评为微软年度医疗保健和生命科学合作伙伴。
在企业版中引入了人工智能代理 Ruby,以提高 IT 和安全运营生产力。
Opportunities:
机会:
Strong emphasis on AI and machine learning within its architecture for data security and cyber recovery, providing a competitive edge in fast cyber recovery times.
Expanded cloud-native protection services, notably for Azure, boosting its presence in both datacenter and cloud workloads.
在其数据安全和网络恢复架构中高度重视人工智能和机器学习,从而在快速的网络恢复时间内提供竞争优势。
扩展了云原生保护服务,尤其是针对 Azure 的保护服务,提高了其在数据中心和云工作负载中的影响力。
Risks:
风险:
The majority of potential risks are mitigated by Rubrik's advanced cyber resilience solutions, however, global IT disruptions could pose challenges, emphasizing the need for robust cyber resilience strategies.
Rubrik的先进网络弹性解决方案可以缓解大多数潜在风险,但是,全球IT中断可能构成挑战,这凸显了强有力的网络弹性战略的必要性。
Tips: This article is generated by AI. The accuracy of the content can not be fully guaranteed. For more comprehensive details, please refer to the IR website. The article is only for investors' reference without any guidance or recommendation suggestions.
提示:本文由 AI 生成。无法完全保证内容的准确性。欲了解更多详情,请访问投资者关系网站。本文仅供投资者参考,不构成任何投资建议。